Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000938090 | SCV001083891 | benign | not provided | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002489253 | SCV002795591 | likely benign | Endometrial carcinoma; Familial adenomatous polyposis 4 | 2021-11-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003169408 | SCV003856346 | likely benign | Hereditary cancer-predisposing syndrome | 2023-03-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomic Medicine, |
RCV004596380 | SCV005090644 | likely benign | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing |